|
Real-time Estimate
Cboe BZX
21:33:59 31/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 24.92 USD | -1.72% |
|
-9.01% | -46.25% |
| 08-13 | Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement | MT |
| 08-06 | Collegium Pharmaceutical, Inc. Revises Earnings Guidance for the Year 2026 | CI |
Company Valuation: Collegium Pharmaceutical, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 650 | 778.9 | 1,004 | 924 | 1,464 | 825.3 | - | - |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -43.61% | - | - |
| Enterprise Value (EV) | 650 | 778.9 | 1,004 | 924 | 1,464 | 825.3 | 825.3 | 825.3 |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -43.61% | 0% | 0% |
| P/E | 10x | -31.4x | 23.9x | 15.4x | 26.8x | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | -0x | 0.3x | -3.83x | - | - | - |
| Capitalization / Revenue | 2.35x | 1.68x | 1.77x | 1.46x | 1.88x | 0.99x | 1x | 1.01x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.99x | 1x | 1.01x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.81x | 2.07x | 2.41x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 1.83x | 2.04x | 2.19x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.86 | -0.74 | 1.29 | 1.86 | 1.73 | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 276.9 | 463.9 | 566.8 | 631.4 | 780.6 | 836.8 | 828.1 | 820.2 |
| EBITDA 1 | 118.3 | 266 | 367 | 401.2 | 460.5 | 455.8 | 399.4 | 342.7 |
| EBIT 1 | 17.63 | 33.32 | 167 | 169.9 | 179.6 | 450.8 | 404.7 | 376.5 |
| Net income | 71.52 | -25 | 48.16 | 69.19 | 62.87 | - | - | - |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 18.68 | 23.20 | 30.78 | 28.65 | 46.30 | 25.35 | 25.35 | 25.35 |
| Nbr of stocks (in thousands) | 34,797 | 33,572 | 32,611 | 32,250 | 31,611 | 32,556 | - | - |
| Announcement Date | 24/02/22 | 23/02/23 | 22/02/24 | 27/02/25 | 26/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 825M | |
| 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | |
| 29.82x | - | - | 2% | 646B | |
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | |
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | |
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.35x | 7.07x | 12.56x | 2.33% | 234B | |
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | |
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | |
| Average | 17.17x | 6.58x | 15.74x | 2.38% | 366.01B | |
| Weighted average by Cap. | 24.24x | 8.07x | 17.81x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COLL Stock
- Valuation Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
